Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS

Recent double-blind, randomized, controlled trials reported that human umbilical cord-derived mesenchymal stem cell (MSC) infusions in COVID-19 patients with acute respiratory distress syndrome (ARDS) could diminish cytokine storm and lung damage. While these outcomes are significant, additional pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Shetty, Ashok K., Shetty, Padmashri A., Zanirati, Gabriele, Jin, Kunlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429629/
https://www.ncbi.nlm.nih.gov/pubmed/34504110
http://dx.doi.org/10.1038/s41536-021-00161-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429629/
https://www.ncbi.nlm.nih.gov/pubmed/34504110
http://dx.doi.org/10.1038/s41536-021-00161-z

Ejemplares similares